However, further studies are required; first, as the expression level of the Notch1 ICD did not correlate with AML outcome (109), and second, a separate study reported activating mutations of β-catenin in mouse osteoblasts that induced AML development through Jag1-induced Notch activation (110). This evidence concerns the gene NOTCH1 and acute myeloid leukemia.